Constitutively active protein phosphatase 1 alpha causes Rb-dependent G1 arrest in human cancer cells
Constitutively active protein phosphatase 1 alpha causes Rb-dependent G1 arrest in human cancer cells
复制标题
DOI:
10.1016/s0960-9822(06)00185-0
复制
发表时间:
1997-06-01
期刊:
影响因子:
9.2
通讯作者:
Liu, CWY
中科院分区:
文献类型:
--
作者:
Berndt, N;Dohadwala, M;Liu, CWY
Background: The retinoblastoma protein (Rb) needs to be phosphorylated by cyclin-dependent kinases (CDKs) before mammalian cells can enter the S phase of the cell cycle. As protein phosphatase 1 (PP1) activates Rb and is itself a target for inhibitory phosphorylation by CDKs in vitro, we asked whether any effects of PP1 on cell cycle progression depend on its phosphorylation and are mediated through Rb.Results: Using electrotransfer of recombinant protein into Rb-positive and Rb-negative cells, we have compared the effects of a wild-type PP1 catalytic subunit, PP1 alpha, and a constitutively active mutant of this subunit (PP1 alpha T320A) on G1 progression, proliferation rates, and cell viability. In treated cells, PP1 alpha levels were elevated 6-16-fold and remained stable for at least 48 hours. In Rb-positive cells, PP1 alpha T320A, but not PP1 alpha, caused cell cycle arrest in late G1, which was associated with a lack of Rb phosphorylation. In Rb-negative cells, neither wild-type nor mutant phosphatase caused any change in cell cycle progression. Increased cell death was observed in both Rb-positive and Rb-negative cells, however, upon introduction of excess PP1 alpha.Conclusions: The difference between the effects of wild-type and mutant forms of PP1 alpha suggests that PP1 alpha has the potential to arrest cell growth in G1 unless it is inactivated by periodic phosphorylation at Thr320, presumably by CDKs that regulate passage through the G1-S cell cycle transition. Together, the effects in both cell types suggest that PP1 alpha requires functional Rb to induce growth arrest, and that possibly another pool of PP1 alpha induces cell death. This identifies PP1 as a potential target for therapeutic anti-proliferative strategies.